FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,000 | – | 452 | +3376.9% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 13 | -97.4% | 0.00% | – |
| Q2 2018 | $8,000 | -11.1% | 502 | -1.2% | 0.00% | – |
| Q1 2018 | $9,000 | +80.0% | 508 | +104.8% | 0.00% | – |
| Q4 2017 | $5,000 | -50.0% | 248 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | +11.1% | 248 | -14.8% | 0.00% | – |
| Q2 2017 | $9,000 | +12.5% | 291 | +35.3% | 0.00% | – |
| Q1 2017 | $8,000 | -11.1% | 215 | +15.6% | 0.00% | – |
| Q4 2016 | $9,000 | -10.0% | 186 | 0.0% | 0.00% | – |
| Q3 2016 | $10,000 | +66.7% | 186 | +26.5% | 0.00% | – |
| Q2 2016 | $6,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |